Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice.

AUTOR(ES)

Ofek, I

RESUMO

Polymyxin B nonapeptide, derived by cleavage of the fatty acyl diaminobutyric acid from polymyxin B, is considerably less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes. The peptide rendered all 53 polymyxin-susceptible strains tested more susceptible to novobiocin, lowering the MIC of novobiocin eightfold or more. The combination of polymyxin B nonapeptide with novobiocin or with erythromycin administered intraperitoneally in multiple doses synergistically protected mice infected with gram-negative bacteria. This combination may be clinically useful because of the apparent rarity of the acquisition of resistance.

Documentos Relacionados

• Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
• Binding of polymyxin B nonapeptide to gram-negative bacteria.
• Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections
• Persistence of associated gram-negative bacteria in experimental actinomycotic lesions in mice.
• Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria